CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors.
Li J, Huang S, Zhu H, Shou C, Lin T, Yin X, Zhu Q, Sun D, Li X, Shen L, Li J, Kou Y, Zhou Y, Zhang B, Qian H, Yu J, Zhou Y, Tang L, Zhang X.
Li J, et al. Among authors: shou c.
Eur Radiol. 2023 Nov 10. doi: 10.1007/s00330-023-10383-y. Online ahead of print.
Eur Radiol. 2023.
PMID: 37947835